India stopped producing the two input drugs about three decades ago and since then it has relied on China for their supplies. "As of now, we are largely dependent on China. With the initiative of the production-linked-incentive scheme, companies like Aurobindo are coming up with fermentation-based products like PenG," said Ravi Uday Bhaskar, director general, Pharmaceutical Export Promotion Council (Pharmexcil). "We will be in a better position in the coming few months."
Analysts at IIFL Securities have analyzed import pricing for 16 key APIs/KSMs imported into India. This study shows that API import costs (weighted average) have declined marginally by 2% QoQ in Q1CY23, after having corrected 8% QoQ and 6% QoQ in Q4CY22 and Q3CY22 respectively from the peaks seen in Q2CY22.
Sun Pharma, Dr Reddy's And Cipla Among 55 Firms Selected For Rs 15,000 Crore PLI Scheme For Pharmaceutical Sector swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
The PLI scheme in pharma aims to enhance India's manufacturing capabilities by increasing investment and production, and boosting exports in 10 sectors.
PLI scheme in API: Can it make India king of world pharmacy? What are the challenges, way forward financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.